With an expected growth rate of 9.4% through 2026, the medicinal mushroom market is addressing global mental health needs.
Biopharma company Mycotopia Therapies Inc. (OTC Pink: TPIA) announced it entered the $13-billion medicinal mushroom market with HAVN Life Sciences' Biopharmaceuticals and Ei.Ventures MANA Products. Through the expanded agreement, Mycotopia will have access to HAVN Life’s functional mushrooms and the white label supply and distribution of HAVN’s line of natural OTC health products.
The firms are moving forward to form PSLY.COM; HAVN Life Sciences' functional mushrooms will be used in PSLY.COM, which will also be the name of the recently acquired 12x 12 estate in The Sandbox metaverse.
Shares of Mycotopia closed Friday up over 9% at $3.00.
